PAK4 and central nervous system cancer: Subsequently, the results of the TCGA and CGGA database analyses showed that PAK4 mRNA levels were greater in high-grade gliomas, and Kaplan‒Meier analysis of PAK4 indicated that patients with low PAK4 expression had longer survival (Fig. 3C, D).